MND Association Taskforce on Interleukin 2 – FAQs
The MND Association has published a series of very informative questions and answers in relation to the exciting MND treatment candidate low dose Interleukin 2. You can read them here.
Most importantly we await the full publication of the trial results.
We are United2EndMND - Changing the conversation 